Intuitive(ISRG)2025-01-23 21:03Revenue Growth - Total revenue for Q4 2024 increased by 25% to $2,413.5 million compared to $1,928.3 million in Q4 2023[2] - Instruments and accessories revenue grew by 23% to $1,411.5 million in Q4 2024 from $1,143.7 million in Q4 2023[2] - Recurring revenue accounted for 80% of total revenue in Q4 2024, slightly down from 82% in Q4 2023[2] System Placements - Da Vinci Surgical System placements in the US increased by 36% to 284 units in Q4 2024 from 209 units in Q4 2023[2] - Da Vinci SP Systems placements surged by 58% to 30 units in Q4 2024 from 19 units in Q4 2023[2] - Ion System placements rose by 57% to 69 units in Q4 2024 from 44 units in Q4 2023[2] - The installed base of Da Vinci Surgical Systems increased by 15% to 9,902 units in 2024 from 8,606 units in 2023[2] - Average selling price of systems increased by 12% to $1.59 million in Q4 2024 from $1.42 million in Q4 2023[2] Procedure Growth - Total worldwide procedures increased by 17% to 2,683 thousand in 2024 from 2,286 thousand in 2023[4] - General Surgery procedures outside the US grew by 35% to 254 thousand in 2024 from 188 thousand in 2023[4]